Anhui Anke Biotechnology (Group) Co., Ltd. (SHE:300009)
8.23
+0.13 (1.60%)
Jul 10, 2026, 3:04 PM CST
SHE:300009 Market Cap
SHE:300009 has a market cap or net worth of 13.72 billion as of July 10, 2026. Its market cap has decreased by -8.11% in one year.
Market Cap
13.72B
Enterprise Value
12.25B
Revenue
2.56B
Ranking
n/a
PE Ratio
19.63
Stock Price
8.23
Market Cap Chart
Since October 30, 2009, SHE:300009's market cap has increased from 4.21B to 13.72B, an increase of 226.16%. That is a compound annual growth rate of 7.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 13.72B | -14.06% |
| Dec 31, 2025 | 15.97B | 10.76% |
| Dec 31, 2024 | 14.41B | -15.68% |
| Dec 29, 2023 | 17.09B | 9.42% |
| Dec 30, 2022 | 15.62B | -27.16% |
| Dec 31, 2021 | 21.45B | 7.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinocelltech Group | 17.06B |
| Chengdu Olymvax Biopharmaceuticals | 16.14B |
| HitGen | 13.40B |
| Jinyu Bio-technology | 13.31B |
| Mabwell (Shanghai) Bioscience | 13.29B |
| BrightGene Bio-Medical Technology | 12.97B |
| InventisBio | 12.46B |
| Tibet Cheezheng Tibetan Medicine | 11.33B |